Inhibition of the 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) as a novel approach to type 2 diabetes treatment.

被引：0
|
作者：
Barf, T
Vallgårda, J
Kurz, G
Alberts, P
Abrahmsen, L
机构：
[1] Biovitrum, Dept Med Chem, SE-75137 Uppsala, Sweden
[2] Biovitrum, Dept Struct Chem, SE-75137 Uppsala, Sweden
[3] Biovitrum, Dept Biol, SE-75137 Uppsala, Sweden
[4] Biovitrum, Dept Assay Dev & Screening, SE-75137 Uppsala, Sweden
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 225卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
188-MEDI
引用
收藏
页码：U207 / U207
页数：1
相关论文
共 50 条
  • [21] 11β-HSD1 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease
    Anderson, Anna
    Walker, Brian R.
    DRUGS, 2013, 73 (13) : 1385 - 1393
  • [22] Possible pathogenetic role of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) gene polymorphisms in arterial hypertension
    Morales, Mauricio A.
    Carvajal, Cristian A.
    Ortiz, Eugenia
    Mosso, Lorena M.
    Artigas, Rocio A.
    Owen, Gareth I.
    Fardella, Carlos E.
    REVISTA MEDICA DE CHILE, 2008, 136 (06) : 701 - 710
  • [23] Discovery of pyridyl sulfonamide 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors for the treatment of metabolic disorders
    Yoon, David S.
    Wu, Shung C.
    Seethala, Ramakrishna
    Golla, Rajasree
    Nayeem, Akbar
    Everlof, John G.
    Gordon, David A.
    Hamann, Lawrence G.
    Robl, Jeffrey A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (21) : 5045 - 5049
  • [24] Hupehenols A-E, Selective 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitors from Viburnum hupehense
    Chen, Xuan-Qin
    Shao, Li-Dong
    Pal, Mahesh
    Shen, Yu
    Cheng, Xiao
    Xu, Gang
    Peng, Li-Yan
    Wang, Kou
    Pan, Zheng-Hong
    Li, Ming-Ming
    Leng, Ying
    He, Juan
    Zhao, Qin-Shi
    JOURNAL OF NATURAL PRODUCTS, 2015, 78 (02): : 330 - 334
  • [25] Discovery of novel, potent benzamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model
    Julian, Lisa D.
    Wang, Zhulun
    Bostick, Tracy
    Caille, Seb
    Choi, Rebekah
    DeGraffenreid, Michael
    Di, Yongmei
    He, Xiao
    Hungate, Randall W.
    Jaen, Juan C.
    Liu, Jinsong
    Monshouwer, Mario
    McMinn, Dustin
    Rew, Yosup
    Sudom, Athena
    Sun, Daqing
    Tu, Hua
    Ursu, Stefania
    Walker, Nigel
    Yan, Xuelei
    Ye, Qiuping
    Powers, Jay P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 3953 - 3960
  • [26] 11β-hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
    Stulnig, TM
    Waldhäusl, W
    DIABETOLOGIA, 2004, 47 (01) : 1 - 11
  • [27] 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitors Still Improve Metabolic Phenotype in Male 11β-HSD1 Knockout Mice Suggesting Off-Target Mechanisms
    Harno, Erika
    Cottrell, Elizabeth C.
    Yu, Alice
    DeSchoolmeester, Joanne
    Gutierrez, Pablo Morentin
    Denn, Mark
    Swales, John G.
    Goldberg, Fred W.
    Bohlooly-Y, Mohammad
    Andersen, Harriet
    Wild, Martin J.
    Turnbull, Andrew V.
    Leighton, Brendan
    White, Anne
    ENDOCRINOLOGY, 2013, 154 (12) : 4580 - 4593
  • [28] 11β-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
    T. M. Stulnig
    W. Waldhäusl
    Diabetologia, 2004, 47 : 1 - 11
  • [29] Functional Effects of Polymorphisms in the Human Gene Encoding 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1): A Sequence Variant at the Translation Start of 11β-HSD1 Alters Enzyme Levels
    Malavasi, Elise L. V.
    Kelly, Val
    Nath, Nikita
    Gambineri, Alessandra
    Dakin, Rachel S.
    Pagotto, Uberto
    Pasquali, Renato
    Walker, Brian R.
    Chapman, Karen E.
    ENDOCRINOLOGY, 2010, 151 (01) : 195 - 202
  • [30] Population Pharmacokinetic/Pharmacodynamic Model of Subcutaneous Adipose 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Activity After Oral Administration of AMG 221, a Selective 11β-HSD1 Inhibitor
    Gibbs, John P.
    Emery, Maurice G.
    McCaffery, Ian
    Smith, Brian
    Gibbs, Megan A.
    Akrami, Anna
    Rossi, John
    Paweletz, Katherine
    Gastonguay, Marc R.
    Bautista, Edgar
    Wang, Minghan
    Perfetti, Riccardo
    Daniels, Oranee
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (06): : 830 - 841
12345